Liu, JiahaoNair, VijiZhao, Yi-yangChang, Dong-yuanLimonte, ChristineBansal, NishaFermin, DamianEichinger, FelixTanner, Emily C.Bellovich, Keith A.Steigerwalt, SusanBhat, ZeenatHawkins, Jennifer J.Subramanian, LalitaRosas, Sylvia E.Sedor, John R.Vasquez, Miguel A.Waikar, Sushrut S.Bitzer, MarkusPennathur, SubramaniamBrosius, Frank C.De Boer, IanChen, MinKretzler, MatthiasJu, WenjunKidney Precision Medicine ProjectMichigan Translational Core C-PROBE Investigator Group2024-10-222024-10-222022Liu J, Nair V, Zhao YY, et al. Multi-Scalar Data Integration Links Glomerular Angiopoietin-Tie Signaling Pathway Activation With Progression of Diabetic Kidney Disease. Diabetes. 2022;71(12):2664-2676. doi:10.2337/db22-0169https://hdl.handle.net/1805/44126Diabetic kidney disease (DKD) is the leading cause of end-stage kidney disease (ESKD). Prognostic biomarkers reflective of underlying molecular mechanisms are critically needed for effective management of DKD. A three-marker panel was derived from a proteomics analysis of plasma samples by an unbiased machine learning approach from participants (N = 58) in the Clinical Phenotyping and Resource Biobank study. In combination with standard clinical parameters, this panel improved prediction of the composite outcome of ESKD or a 40% decline in glomerular filtration rate. The panel was validated in an independent group (N = 68), who also had kidney transcriptomic profiles. One marker, plasma angiopoietin 2 (ANGPT2), was significantly associated with outcomes in cohorts from the Cardiovascular Health Study (N = 3,183) and the Chinese Cohort Study of Chronic Kidney Disease (N = 210). Glomerular transcriptional angiopoietin/Tie (ANG-TIE) pathway scores, derived from the expression of 154 ANG-TIE signaling mediators, correlated positively with plasma ANGPT2 levels and kidney outcomes. Higher receptor expression in glomeruli and higher ANG-TIE pathway scores in endothelial cells corroborated potential functional effects in the kidney from elevated plasma ANGPT2 levels. Our work suggests that ANGPT2 is a promising prognostic endothelial biomarker with likely functional impact on glomerular pathogenesis in DKD.en-USPublisher PolicyAngiopoietinsBiomarkersDiabetes mellitusDiabetic nephropathiesDisease progressionEndothelial cellsChronic kidney failureArticle